[OKT3 for recipients with steroid-resistant acute rejection after liver transplantation]

Zhonghua Gan Zang Bing Za Zhi. 2007 Nov;15(11):857-8.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Graft Rejection / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3